These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21425314)

  • 1. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
    Nguyen LH; Ko S; Wong SS; Tran PS; Trinh HN; Garcia RT; Ahmed A; Lutchman GA; Keeffe EB; Nguyen MH
    Hepatology; 2011 Jun; 53(6):1839-45. PubMed ID: 21425314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions.
    Bini EJ; Perumalswami PV
    Hepatology; 2010 Mar; 51(3):759-66. PubMed ID: 20140950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.
    Rockenbach G; De Melo Neto AJ; Barcellos NT; Wolff FH
    Hepatology; 2012 May; 55(5):1640; author reply 1640. PubMed ID: 21748759
    [No Abstract]   [Full Text] [Related]  

  • 4. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
    Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
    Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
    De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
    Marot A; Belaid A; Orlent H; Sersté T; Michielsen P; Colle I; Laleman W; de Galocsy C; Reynaert H; D'Heygere F; Moreno C; Doerig C; Henrion J; Deltenre P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):656-663. PubMed ID: 28867077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients.
    Yeh ML; Huang CI; Huang CF; Hsieh MH; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
    J Infect Dis; 2019 Apr; 219(8):1224-1233. PubMed ID: 30452671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcome of chronic viral hepatitis with acute exacerbation in patients with concurrent infections of hepatitis B and C virus.
    Chuang CS; Tung SY; Lee IL; Shen CH; Wei KL; Chang TS; Wu CS
    Dig Dis Sci; 2008 Feb; 53(2):511-6. PubMed ID: 17682944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional study.
    Yan LB; Rao HY; Ma YJ; Bai L; Chen EQ; Du LY; Yang RF; Wei L; Tang H;
    BMJ Open; 2016 Oct; 6(10):e012016. PubMed ID: 27733412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Tyson GL; Kramer JR; Duan Z; Davila JA; Richardson PA; El-Serag HB
    Hepatology; 2013 Aug; 58(2):538-45. PubMed ID: 23505059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada.
    Binka M; Butt ZA; McKee G; Darvishian M; Cook D; Wong S; Yu A; Alvarez M; Samji H; Wong J; Krajden M; Janjua NZ
    Int J Infect Dis; 2021 May; 106():246-253. PubMed ID: 33771673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients.
    Wiegand SB; Jaroszewicz J; Potthoff A; Höner Zu Siederdissen C; Maasoumy B; Deterding K; Manns MP; Wedemeyer H; Cornberg M
    Clin Microbiol Infect; 2015 Jul; 21(7):710.e1-9. PubMed ID: 25882360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and current management of hepatitis B and C in China.
    Sun YT; Zhang YX; Tang H; Mao Q; Wang XZ; Zhang LY; Chen H; Zhong YN; Lin SM; Zhang DZ
    World J Gastroenterol; 2014 Oct; 20(37):13582-90. PubMed ID: 25309089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
    Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
    Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    Yu G; Chi X; Wu R; Wang X; Gao X; Kong F; Feng X; Gao Y; Huang X; Jin J; Qi Y; Tu Z; Sun B; Zhong J; Pan Y; Niu J
    PLoS One; 2015; 10(9):e0139015. PubMed ID: 26422607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.